Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Mar 17, 2023 | Mar 22, 2023 | Mayer Eldon C. III Ex VP Chief Commerc. Officer | Sell | Eiger Biopharmaceuticals, Inc. | EIGR | $1.07 | $4,704 | -7.27% |
Mar 14, 2022 | Mar 15, 2022 | Mayer Eldon C. III Ex VP Chief Commerc. Officer | Sell | Eiger Biopharmaceuticals, Inc. | EIGR | $5.6 | $9,275 | -2.67% |
Jan 07, 2022 | Jan 12, 2022 | Mayer Eldon C. III Ex VP Chief Commerc. Officer | Sell | Eiger Biopharmaceuticals, Inc. | EIGR | $4.95 | $7,722 | -3.27% |
Jan 08, 2021 | Jan 11, 2021 | Mayer Eldon C. III Ex VP Chief Commerc. Officer | Sell | Eiger Biopharmaceuticals, Inc. | EIGR | $11.68 | $19,739 | -4.51% |
Jan 24, 2020 | Jan 30, 2020 | Mayer Eldon C. III Ex VP Chief Commerc. Officer | Buy | Eiger Biopharmaceuticals, Inc. | EIGR | $13.52 | $67,603 | +14.29% |
Nov 29, 2018 | Nov 30, 2018 | Mayer Eldon C. III Dir | Buy | Eiger Biopharmaceuticals, Inc. | EIGR | $10.21 | $40,840 | +13.79% |
Nov 26, 2018 | Nov 29, 2018 | Mayer Eldon C. III Dir | Buy | Eiger Biopharmaceuticals, Inc. | EIGR | $9.9 | $207,998 | +50.00% |
Sep 10, 2018 | Sep 12, 2018 | Mayer Eldon C. III EVP Chief Commercial Officer | Buy | Rigel Pharmaceuticals Inc | RIGL | $3.26 | $325,550 | +31.75% |
Aug 23, 2018 | Aug 27, 2018 | Mayer Eldon C. III EVP Chief Commercial Officer | Buy | Rigel Pharmaceuticals Inc | RIGL | $2.82 | $282,320 | +46.51% |
- 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.